Corporate updates from Dyadic, Ouster, and Watsco

Several companies provided updates during recent investment conferences and financial disclosures.

Dyadic Applied Biosolutions, led by President and COO Joe Hazelton, announced its transition from a research and development organization to a commercial entity. The company is utilizing gene expression technology to address global demand for proteins across the life sciences, food and nutrition, and bioindustrial sectors, specifically focusing on animal-free solutions.

Ouster, Inc. saw increased interest from institutional investors during the second quarter. Tidal Investments LLC acquired a new position of 34,741 shares, valued at approximately $2.17 million. Other firms, including Integrated Wealth Concepts LLC and Orion Capital Management LLC, also adjusted their holdings in the company.

Watsco, Inc. participated in Morgan Stanley's 14th Annual Laguna Conference. During the presentation, Executive VP Barry Logan discussed the company's scale and its acquisitive strategy, noting that Watsco leverages its capital and relationships to acquire long-standing family businesses.